AKBA
Akebia Therapeut (AKBA)
NASDAQ
$0.57+$0.007 (+1.21%)
Price as of Oct 22, 2026 7:59 PM EDT
  • $162.2M
    Market Cap
  • -80.42%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 62
Valuation
AKBA
vs History
vs S&P 500
Profitability
1
Growth
1
Low Earnings Volatility
1

Momentum Score

Score: 21
Valuation
AKBA
vs History
vs S&P 500
3-Month Momentum
-24.62%
12-Month Momentum
-68.59%
3-Month Risk Adjusted Momentum
-68.96%
12-Month Risk Adjusted Momentum
-89.79%

True Yield

N/A
Valuation
AKBA
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
N/A
Net Debt Paydown Yield
-0.13%

Financial Health Score

Score: 85
Valuation
AKBA
vs History
vs S&P 500
Ohlson's O-Score
7